List of Chapters/Sections(Table Of Content)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adeno-Associated Virus (AAV) Gene Therapy
1.2 Key Market Segments
1.2.1 Adeno-Associated Virus (AAV) Gene Therapy Segment by Type
1.2.2 Adeno-Associated Virus (AAV) Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adeno-Associated Virus (AAV) Gene Therapy Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adeno-Associated Virus (AAV) Gene Therapy Market Competitive Landscape
3.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Company (2019-2024)
3.2 Adeno-Associated Virus (AAV) Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Adeno-Associated Virus (AAV) Gene Therapy Market Size Sites, Area Served, Product Type
3.4 Adeno-Associated Virus (AAV) Gene Therapy Market Competitive Situation and Trends
3.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Concentration Rate
3.4.2 Global 5 and 10 Largest Adeno-Associated Virus (AAV) Gene Therapy Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Adeno-Associated Virus (AAV) Gene Therapy Value Chain Analysis
4.1 Adeno-Associated Virus (AAV) Gene Therapy Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Adeno-Associated Virus (AAV) Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2019-2024)
6.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Type (2019-2024)
7 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (M USD) by Application (2019-2024)
7.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Application (2019-2024)
8 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Region
8.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region
8.2 North America
8.2.1 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Creative Biolabs
9.1.1 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.1.2 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.1.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
9.1.5 Creative Biolabs Business Overview
9.1.6 Creative Biolabs Recent Developments
9.2 Affinia Therapeutics
9.2.1 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.2.2 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.2.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
9.2.5 Affinia Therapeutics Business Overview
9.2.6 Affinia Therapeutics Recent Developments
9.3 Spark Therapeutics
9.3.1 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.3.2 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.3.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
9.3.5 Spark Therapeutics Business Overview
9.3.6 Spark Therapeutics Recent Developments
9.4 AGC Biologics
9.4.1 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.4.2 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.4.4 AGC Biologics Business Overview
9.4.5 AGC Biologics Recent Developments
9.5 StrideBio
9.5.1 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.5.2 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.5.4 StrideBio Business Overview
9.5.5 StrideBio Recent Developments
9.6 SIRION Biotech
9.6.1 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.6.2 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.6.4 SIRION Biotech Business Overview
9.6.5 SIRION Biotech Recent Developments
9.7 Neurophth Biotechnology
9.7.1 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.7.2 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.7.4 Neurophth Biotechnology Business Overview
9.7.5 Neurophth Biotechnology Recent Developments
9.8 Belief BioMed
9.8.1 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.8.2 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.8.4 Belief BioMed Business Overview
9.8.5 Belief BioMed Recent Developments
9.9 BiBo Biopharma Engineering Co., LTD.
9.9.1 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.9.2 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.9.4 BiBo Biopharma Engineering Co., LTD. Business Overview
9.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments
9.10 Beihai Kangcheng
9.10.1 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.10.2 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.10.4 Beihai Kangcheng Business Overview
9.10.5 Beihai Kangcheng Recent Developments
9.11 PackGene Biotech
9.11.1 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.11.2 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.11.4 PackGene Biotech Business Overview
9.11.5 PackGene Biotech Recent Developments
9.12 Sarepta Therapeutics
9.12.1 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.12.2 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.12.4 Sarepta Therapeutics Business Overview
9.12.5 Sarepta Therapeutics Recent Developments
9.13 Carbon BioSciences
9.13.1 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.13.2 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.13.4 Carbon BioSciences Business Overview
9.13.5 Carbon BioSciences Recent Developments
9.14 Kelonia Therapeutics
9.14.1 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.14.2 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.14.4 Kelonia Therapeutics Business Overview
9.14.5 Kelonia Therapeutics Recent Developments
9.15 Roche
9.15.1 Roche Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.15.2 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.15.4 Roche Business Overview
9.15.5 Roche Recent Developments
9.16 Remedium Bio
9.16.1 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.16.2 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.16.4 Remedium Bio Business Overview
9.16.5 Remedium Bio Recent Developments
10 Adeno-Associated Virus (AAV) Gene Therapy Regional Market Forecast
10.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast
10.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Region
10.2.4 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adeno-Associated Virus (AAV) Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Type (2025-2030)
11.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
